To evaluate the association between nocturia and the incidence of depressive symptoms.
Introduction
Nocturia, the occurrence of nocturnal awakenings to void urine, is a common and bothersome urological symptom that is present in both genders. Its prevalence increases with age to a Proportion of up to 60% (nocturnal voids [NVs] ≥2 times/night) in the elderly aged >60 years [1, 2] . Nocturia is frequently accompanied by sleep disturbances and may cause circadian misalignment between internal and environmental rhythms as a result of nighttime activity [3, 4] . The circadian timing systems control the frequency of NVs by decreasing nocturnal urine production and increasing nighttime bladder storage capacity, and the circadian misalignment partly explains the aetiology of nocturia and sleep disturbances in the elderly [5] . Thus, the associations between nocturia, sleep disturbances and circadian misalignment suggest vicious cycles, possibly enhancing the likelihood of causes related to depression [6] .
The prevalence of depression has increased in recent decades in addition to the risks of associated dementia, cardiovascular disease and early mortality [7] [8] [9] ; however, the aetiology and methods to prevent depression remain poorly defined. Depression is closely associated with sleep disturbances and circadian misalignment, presenting a plausible mechanism that may underlie depression risk [6, 10, 11] . A previous epidemiological study suggested a cross-sectional association between nocturia and depressive symptoms that was stronger among men than among women [12] . By contrast, a longitudinal study failed to detect a significant association between nocturia and the incidence of depressive symptoms [13] . In addition, a recent systematic review indicated a crosssectional association between nocturia and depressive symptoms, but a lack of longitudinal evidence for an association [14] .
The aim of the present study was to determine whether nocturia is longitudinally associated with a subsequent depression risk and to identify possible gender differences in the association between nocturia and depression risk in the general elderly population.
Participants and Methods

Study Participants
The HEIJO-KYO cohort included 1 127 community-dwelling elderly participants aged ≥60 years, assembled with the cooperation of local residents' associations and elderly residents' clubs. The participants had completed a baseline survey between September and April 2010-2014 [15] . Of the 1 110 participants who completed the Geriatric Depression Scale (GDS) questionnaire and a standardized urination diary at baseline, 176 were excluded because of reported depressive symptoms (GDS score ≥6; n = 166) or a diagnosis of depression and use of antidepressants at baseline (n = 19), leaving 934 eligible participants in the present study.
Measurement of Nocturnal Void Frequency and Depressive Symptoms
Nocturnal void frequency, except for the last void at bedtime and the first void in the morning, was logged using a standardized urination diary for one night. Nocturia was defined as an NV frequency of ≥2 voids per night. The intraindividual correlations of NV frequency were evaluated in the first 189 participants of our cohort, and the agreement for nocturia between the two data sets was moderate (j coefficient = 0.55) [16] . Single voided urine volume was calculated as the total nocturnal voided urine volume divided by the NV frequency, including the first morning void.
Depressive symptoms were evaluated at baseline and followup (between August 2014 and January 2015) using the short version (15 items) of the GDS, and scores ≥6 indicated the presence of depressive symptoms. The sensitivity and specificity for clinically diagnosed depression at this threshold are reportedly 0.85-0.91 and 0.68-0.78, respectively [17] .
Measurement of Covariates
Current smoking, drinking and socio-economic status were assessed using a standardized questionnaire. Body mass index was calculated as body weight divided by the square of body height (kg/m 2 ). The presence of hypertension was determined on the basis of medical history and current use of antihypertensive drugs. Diabetes mellitus was determined on the basis of medical history, current use of antidiabetic therapy and fasting plasma glucose and glycated haemoglobin levels. Chronic kidney disease (CKD) was defined as estimated GFR < 60 mL/min/1.73 m 2 using the formula from the CKD-EPI definition for Japanese people [18] . BPH was determined on the basis of self-reported medical history and current use of anti-BPH therapy. Physical activity was assessed using the International Physical Activity Questionnaire [19] . A standardized sleep diary was used to estimate bedtimes and duration in bed for two consecutive nights. Subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire, and sleep disturbances were defined as PSQI score ≥6 [20] . The day length (sunrise to sunset), based on the measurement days in Nara, Japan (latitude 34°N), was extracted from the National Astronomical Observatory of Japan's website.
Statistical Analyses
Means and medians were compared between the dichotomous groups using the unpaired t-test and the Mann-Whitney Utest, respectively. The chi-squared test was used to compare categorical data. Sleep diary data from the two measurement days were averaged. Hazard ratios (HRs) for incident depressive symptoms in relation to baseline NV frequency were estimated using a Cox proportional hazard model, adjusted for variables associated with nocturia (Table 1) , such as age (≥70 years vs <70 years), gender (men vs women), alcohol consumption (≥30 g/day vs <30 g/day), day length (per quartile), hypertension (yes vs no), CKD (yes vs no), BPH (yes vs no), sleep disturbances (yes vs no), bedtime (per 1 h delay), and duration in bed (per 1 h). The mean, median or proportion was substituted for missing data of these independent variables. All analyses were performed using SPSS version 19.0 for Windows (IBM-SPSS, Inc., Chicago, IL, USA). A two-sided P value of <0.05 was taken to indicate statistical significance.
Results
Of the 934 eligible participants without baseline depressive symptoms, 866 (92.7%) participated in a follow-up assessment and completed the GDS questionnaire. The mean age of the 866 participants was 71.5 AE 6.9 years, and 416 (48.0%) were men. At baseline, the nocturia group (NV frequency ≥2 times/night, n = 239) were significantly older, included more men, had a higher prevalence of hypertension, CKD, BPH and sleep disturbances, had an earlier bedtime, and had a longer duration in bed compared with the nonnocturia group (NV frequency <2 times/night, n = 627; Table 1 ).
During follow-up (median duration 23 months; interquartile range 17-34 months), the mean increases in the GDS scores from baseline to follow-up were 0.49 (95% CI 0.36-0.63), and 75 participants (8.7%) reported the development of depressive symptoms. Longitudinal analysis using the Cox proportional hazard models (Table 2) suggested that the nocturia group exhibited a significantly higher HR for incident depressive symptoms than the non-nocturia group (HR 1.88, 95% CI 1.19-2.98; P = 0.007; unadjusted model). The value remained significant after adjustment for age, gender, drinking status and day length (adjusted model 1); variables in model 1 plus clinical variables (hypertension and CKD; HR 1.69, 95% CI 1.05-2.73; P = 0.032; adjusted model 2); and variables in model 1 plus sleep variables (sleep disturbances, bedtime, duration in bed; HR 1.68, 95% CI 1.02-2.75; P = 0.040; adjusted model 3). Sensitivity analysis using a definition of nocturia as a frequency of 0, 1 and ≥2 voids per night showed significant increases in HR for incident depressive symptoms in the ≥2 voiding group (HR 2.35, 95% CI 1.25-4.40; P = 0.008; Table S1 ) but not in the one voiding group compared with the no voiding group (HR 1.42, 95% CI 0.75-2.69; P = 0.28).
In the analysis stratified by gender (Table 3) , the association between nocturia and the incidence of depressive symptoms was significant in men (HR 2.74, 95% CI 1.41-5.35; P = 0.003; unadjusted model), but not in women (HR 1.28; 95% CI 0.61-2.71; P = 0.51; unadjusted model). This gender difference in the association between nocturia and the incidence of depressive symptoms remained significant even after adjustment for potential confounders (age, hypertension, CKD, BPH, sleep disturbances, bedtime and duration in bed; men: HR 2.51, 95% CI 1.27-4.97; P = 0.008; women: HR 1.14; 95% CI 0.53-2.44; P = 0.74; adjusted model 2; men: HR 2.32; 95% CI 1.17-4.59; P = 0.016; women: HR 1.23, 95% CI 0.55-2.71; P = 0.62; adjusted model 3). In the linear regression analysis using continuous data of GDS score in men, nocturia was significantly associated with subsequent increase in GDS score (b = 0.46, 95% CI 0.05-0.86; P = 0.027; unadjusted model). Furthermore, sensitivity analysis excluding men with baseline GDS score = 5 (n = 19), the association between nocturia and the incidence of depressive symptoms was consistently significant (HR 2.44; 95% CI 1.16-5.17; P = 0.019; unadjusted model).
The nocturia group exhibited significantly larger nocturnal urine volume and smaller single voided urine volume than those in the non-nocturia group in men (87.4 vs 65.5 mL/h, P <0.001 and 222.0 vs 338.4 mL/void, P <0.001, respectively); however, there were no significant differences in nocturnal and single voided urine volumes between the groups with and without incident depressive symptoms (79.5 vs 72.5 mL/h, P = 0.21 and 264.5 vs 301.1 mL/void, P = 0.12, respectively). In addition, the significant association between nocturia and the incidence of depressive symptoms did not change after further adjustment for baseline nocturnal urine volume or single voided urine volume in addition to age (HR 2.27, 95% CI 1.11-4.64; P = 0.025; HR 2.53; 95% CI 1.20-5.36; P = 0.015, respectively).
Discussion
The results of the present study suggest that nocturia with a frequency of ≥2 NVs is longitudinally and significantly associated with a higher HR for incident depressive symptoms in the general elderly population, independently of several known risk factors for depression such as aging, hypertension, CKD and sleep disturbances. Furthermore, gender differences may underlie the association, as men with nocturia were found to have a greater risk of depressive symptoms than women.
The present results were consistent with those of previous cross-sectional studies. To the best of our knowledge, the present results are the first positive evidence for the association between nocturia and the incidence of depressive symptoms. A large-scale population-based study in the USA of 5 503 randomly selected samples suggested a crosssectional association between nocturia (≥2 voids) and depressive symptoms [12] . Other epidemiological studies have also indicated significant cross-sectional associations between nocturia and depressive symptoms [21] [22] [23] , but not all [24] . One longitudinal study conducted in Finland that included 1 229 men without baseline depressive symptoms and that classified the frequency of NVs into three categories (0, 1 or 2, or ≥3 voids per night) failed to detect a significant association between nocturia and the incidence of depressive symptoms [13] . Indeed, nocturia is defined by the International Continence Society as ≥1 NV [25]; however, our sensitivity analysis indicated that a frequency of one void per night was not significantly associated with an increased risk of depression. Thus, the results reported in the Finnish study were not significant possibly because of its categorization of nocturia, which differed from the present study.
Gender differences in the longitudinal association between nocturia and the incidence of depressive symptoms were observed in the present study, which was consistent with the results of previous cross-sectional studies. A population-based study in the USA [12] reported a stronger association between nocturia (≥2 voids) and depressive symptoms among men (n = 3 301) than women (n = 2 202; adjusted odds ratio 2.8 vs 1.8, respectively). Likewise, a Swedish study [21] also reported a stronger association between nocturia (≥2 voids) and depressive symptoms among men (n = 609) than women (n = 766; adjusted odds ratio 6.5 vs 2.8, respectively). Similarly, in the present study, the association between nocturia and incident depressive symptoms was stronger among men than women (adjusted HR 2.5 vs 1.1, respectively). Previous studies indicated a significant association between nocturia and depressive symptoms even in women; however, in the present study, no significant associations were detected in women, possibly because of the relatively small sample size and case size. The small sample size also prevented construction of fully adjusted statistical models. Future longitudinal studies with greater numbers of men, women and cases are warranted. Also, further research is needed to establish whether nocturia treatment reduces the depression risk.
Although the mechanisms underlying the effect of nocturia on mood are not fully understood, sleep disturbances and circadian misalignment induced by nocturia may be possible contributors to mood changes. Nocturia is related to disturbances in sleep continuation that may possibly be associated with depressive symptoms [3, 4, 10, 11] , although the present results indicated that the association between nocturia and incident depressive symptoms was independent of subjective sleep disturbances detected at baseline. Nocturia may also cause circadian misalignment between internal and environmental rhythms as a result of physical activity and posture changes at night, possibly increasing depressive symptoms [6] . Furthermore, nocturia is a phenotype of the circadian misalignment in renal or bladder function [5] , although the association between nocturia and incident depressive symptoms was independent of nocturnal and single voided urine volumes at baseline in the present study, which indicates that the impact of nocturia on mood is not dependent on major urological causes.
The present study has some potential limitations in addition to the relatively small sample and case sizes. First, participants were not randomly selected, possibly leading to selection bias. Nevertherless, the variables of body mass index and estimated GFR were similar to corresponding national data in Japan, and the follow-up rate was sufficiently high. Second, NV frequency was measured using a standardized urination diary rather than questionnaires; the assessment was only measured over one night, which possibly led to misclassification of the nocturia status; however, the present data suggest moderate reproducibility of the one night assessment for nocturia. Third, our overnight urine collection protocol required the first morning void be performed at the rising time regardless of the desire for micturition; therefore, the mean volume of single voided urine may be underestimated. In addition, we did not have full information related to treatment for nocturia, although the statistical model indicated that the association between nocturia and incident depressive symptoms was independent of BPH treatment. Finally, the timings of follow-up measurement for depressive symptoms differed among participants, possibly affected by seasons, although most of follow-up measurements (91.5%) were conducted in August to October.
In conclusion, nocturia is significantly associated with an increased risk of depression in the general elderly population. It is independent of several known risk factors such as aging, hypertension, CKD and sleep disturbances. In addition, the results of the present study suggest that gender differences may underlie the association between nocturia and a greater risk for depressive symptoms in men than in women.
